Autoantibody negative new onset Type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: Are these Type 1b diabetes cases?

Diabetes/Metabolism Research and Reviews

Volumn 16, Issue 1, 2000, Pages 8-14

  Tiberti, Claudio ^a   Buzzetti, R ^a   Anastasi, E ^a   Dotta, F ^a   Vasta, M ^b   Petrone, A ^a   Cervoni, M ^a   Torresi, P ^a   Vecci, E ^a   Multari, G ^a   Di Mario, U ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ospedale di Urbino   (Italy)

Author keywords

Autoantibody negative Type 1 diabetic patients; Caucasian; Genetics of Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GANGLIOSIDE GD3; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR1 ANTIGEN; INSULIN ANTIBODY; OXYGENASE; PANCREAS ISLET CELL ANTIBODY; PARIETAL CELL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CAUCASIAN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 0034064298     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1520-7560(200001/02)16:1<8::aid-dmrr77>3.0.co;2-t     Document Type: Article

References (45)

1. Gianani R, Eisenbarth GS. Type 1 Diabetes: Molecular, Cellular and Clinical Immunology. Hum Autoimmunity 1996; 10: 209-229.
2. Wolf E, Spencer KM, Cudworth AG. The genetic susceptibility of Type 1 (insulin dependent) diabetes: Analysis of the HLA-DR association. Diabetologia 1993; 24: 224-230.
3. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin dependent diabetes mellitus. Nature 1987; 329: 599-604.
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl. 1): S5-S19.
5. Atkinson MA, MacLaren NK. Mechanism of disease: the pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1435.
6. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lanceti 1974; ii: 1279-1283.
7. Palmer JP, Asplin CM, Clemons P, et al. Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science 1983; 222: 1337-1339.
8. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
9. Verge CF, Gianani R, Kawasaki E, et al. Prediction of Type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933.
10. Tiberti C, Dotta F, Anastasi E, et al. Anti-ganglioside antibodies in new onset Type 1 diabetic patients and high risk subjects. Autoimmunity 1995; 22: 43-48.
11. Dotta F, Falorni A, Tiberti C, et al. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at Type 1 diabetes onset. J Autoimmunity 1997; 10: 585-588.
12. Verge C, Eisenbarth GS. Autoimmune polyendocrine syndromes. In Williams' Textbook of Endocrinology. 9th Ed. Philadelphia: W.B. Saunders, 1997.
13. Landin-Olsson M, Karlsson FA, Lernmark A, Sundkvist G, and the Diabetes Incidence Study in Sweden Group. Islet cell and Thyrogastric Antibodies in 633 consecutive 15-to 34-yr-old patients in the Diabetes incidence study in Sweden. Diabetes 1992; 41: 1022-1027.
14. Falorni A, Laureti S, Nikoshkov A, et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin Exp Immunol 1997; 107: 341-346.
15. Bao F, Yu L, Babu S, et al. Development of human transglutaminase IgA and IgG autoantibody radioassays: evaluation of patients with Type 1 diabetes mellitus (Abstract). Diabetes 1998; 47 (Suppl. 1): 209A.
16. Cucca F, Muntoni F, Lampis R, et al. Combinations of specific DRB1, DQA1, DQB1, haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993; 37: 85-94.
17. She JX, Bui MM, Tian XH, et al. Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity 1994; 18: 195-203.
18. Donner H, Rau H, Walfish PG, et al. CTLA-4 alanine-17 confers genetic susceptibility to Grave's disease and to Type 1 diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 143-146.
19. Gribben JG, Freeman GJ, Boussiotis VA, et al. CTLA-4 mediated costimulation induces apoptosis of activated huma T lymphocytes. Proc Natl Acad Sci U S A 1994; 92: 811-815.
20. Tïvol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe A. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-547.
21. Nisticò L, Buzzetti R, Pritchard LE, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with Type 1 diabetes. Hum Mol Genet 1996; 5: 1075-1080.
22. Marron MP, Raffel LJ, Garchon HJ, et al. IDDM is associated with CTLA-4 polymorphism in multiple ethnic groups. Hum Mol Genet 1997; 6: 1275-1282.
23. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1972; 28: 1039-1057.
24. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity-onset diabetes of youth in Black Americans. N Engl J Med 1987; 316: 285-291.
25. Pinhas-Hamiel O, Dolan LM, Zeitlers PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997; 20: 484-486.
26. Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Diabetes 1994; 43: 741-745.
27. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories og glucose intolerance. Diabetes 1972; 28: 1039-1057.
28. Vardi P, Dib SA, Tuttleman M, et al. Competitive insulin autoantibody RIA: prospective evaluation of subjects at high risk for development of Type 1 diabetes mellitus. Diabetes 1987; 36: 1286-1291.
29. Di Mario U, Perfetti R, Anastasi E, et al. Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena. Acta Endocrinologica (Copenh) 1990; 122: 303-308.
30. Grubin CE, Daniels T, Toivola B, et al. A novel radioligand binding assay to determine diagnostic accuracy of iso-form specific glutamic acid decarboxylase in a childhood population. Diabetologia 1994; 37: 344-350.
31. Boitard C, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J. Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardization of Cytoplasmic Islet Cell Antibodies. Diabetologia 1988; 31: 451-452.
32. D'Amato M, Sorrentino R. A simple and economical IDRB1 typing procedure combining group specific amplification, DNA heteroduplex and enzyme restriction analysis. Tissue Antigens 1994; 43: 295-298.
33. D'Amato M, Sorrentino R. Short insertious in the partener strands greatly enhance the discriminating power of DNA heteroduplex analysis: resolution of HLA-DQB1 polymorphisms. Nucleic Acids Res 1995; 23: 2078-2079.
34. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, De Groot LJ. CTLA-4 gene polymorphism associated with Graves's Disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80: 41-45.
35. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction on IDDM in the general population; strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-1710.
36. Hagopian WA, Sanjeevi CB, Kockum I, et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1997; 95: 1505-1511.
37. Drell DW, Notkins AL. Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 132-143.
38. Landin-Olsson M, Karlsson A, Dahlquist G, et al. Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989; 32: 387-395.
39. Erlich HA, Zeidler A, Chang J, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 1993; 3: 358-364.
40. Buzzetti R, Nisticò L, Osborn JF, Giovannini C, Chersi A, Sorrentino R. HLA DQA1 and HLA DQB1 gene polymorphisms in Type 1 diabetic patients from central Italy and their use for risk prediction. Diabetes 1993; 42: 1173-1178.
41. Todd JA. The Emperor's new genes, RD Lawrence Lecture. Diabet Med 1993; 11: 6-16.
42. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contribution to susceptibility and resistance to insulin dependent diabetes mellitus. Nature 1987; 329: 599-604.
43. Baisch JM, Week T, Giles R, Hoover M, Statny P, Capra D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 1990; 322: 1836-1841.
44. Pugliese A, Gianani R, Moromisato R, et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes. Diabetes 1995; 44: 608-613.
45. Von Mühlendal KE, Herkenoff H. Long-term course of neonatal diabetes. N Engl J Med 1995; 333: 704-708.